SINGAPORE: The updated JN.1 Novavax/Nuvaxovid COVID-19 vaccine will be offered under the national vaccination programme at ...

With Sanofi (SNY) expected to join the company’s commercialization efforts in 2025, many issues Novavax (NVAX) encountered with the rollout of its COVID-19 shot, Nuvaxovid, in the 2023–24 ...

Dr Clive Dix said that Nuvaxovid has excellent clinical data and – as a it has good stability at fridge temperatures – could be easily rolled out with the flu vaccine next winter, and should ...

The product, called Nuvaxovid, is a protein-based vaccine. Health Canada said the vaccine was updated to target the JN.1 variant, an offshoot of Omicron. Nationally, the JN.1 group is currently ...